Steroid hormones, including progesterone, are known to bind with high affinity (Kd L 1 x 10-0M)toreceptorproteinsoncetheyentertargetcells.Thiscomplex(theprogesteronereceptor) then undergoes a temperature-and/or salt-dependent activation which allows it to migrate to the cell nucleus and to bind to the deoxyribonucleoproteins. The It is now widely accepted that the sequence of events in the mechanism of action of steroid hormones includes: (1) the uptake of the hormone by the target cell, followed by the high-affinity formation of a stereospecific complex with an extranuclear receptor protein, (2) a temperatureand/or ionic-strength-dependent translocation of this hormone-receptor complex to the nucleus, (3) binding of the complex to specific acceptor sites on the chromatin, (4) a qualitative and quantitative stimulation of transcription, resulting in the synthesis of new RNA species, (5) transport of these RNA species to the cytoplasm and subsequent synthesis of new protein on cytoplasmic polyribosomes, and (6) tissue-specific metabolic response (Rasp6, 1971).
It is now widely accepted that the sequence of events in the mechanism of action of steroid hormones includes: (1) the uptake of the hormone by the target cell, followed by the high-affinity formation of a stereospecific complex with an extranuclear receptor protein, (2) a temperatureand/or ionic-strength-dependent translocation of this hormone-receptor complex to the nucleus, (3) binding of the complex to specific acceptor sites on the chromatin, (4) a qualitative and quantitative stimulation of transcription, resulting in the synthesis of new RNA species, (5) transport of these RNA species to the cytoplasm and subsequent synthesis of new protein on cytoplasmic polyribosomes, and (6) tissue-specific metabolic response (Rasp6, 1971 ).
In the chick oviduct system, the cytoplasmic receptor for progesterone has been extensively purified Schrader et al., 1974; Kuhn et al., 1975 ; W. T. Schrader, personal communication) and shown to consist of two 4S binding components, termed A and B, which are present in near-equal amounts and have mol.wts. of 110000 and 117000 respectively. Receptor A has been reported to bind to DNA, and receptor B to purified oviduct chromatin Vol. 156 . In the past 8 years, various laboratories have demonstrated binding of steroid-receptor complexes to isolated nuclei or chromatin in vitro. This nuclear binding appears to have many of the same properties as that which occurs in vivo. Under conditions in vitro and in vivo, the nuclear binding is of high affinity, and requires a temperature-dependent translocation ofthe steroidreceptor complex to the nuclei. The steroid-receptor complex can then be dissociated from nuclei under high-ionic-strength conditions.
Previous work in this and in other laboratories
using PH]progesterone complexed with the oviduct cytosolreceptor (progesteronereceptor) has suggested that 90% of the total nuclear binding in the system in vitro is associated with the nuclear chromatin (Spelsberg et al., 1971b; Spelsberg et al., 1972; Spelsberg, 1974) . Under physiological ionic conditions, the extent of binding of the progesterone-receptor complex to the chromatin from the chick oviduct appeared to be greater than that to spleen, heart or other tissue chromatins.
The studies presented here demonstrate that the nuclear binding of the progesterone receptor in vitro to isolated nuclei from the oviducts of laying hens has the same properties and requirements as reported for the immature chick system (Spelsberg et al., 1971b) . A detailed assessment of this nuclear binding of the progesterone-receptor complex in vitro to hen organ nuclei, including many properties of this interaction as well as the tissue specificity, has been made. Further, evidence is presented for the presence ofmultiple binding sites for the progesterone receptor which probably represent those described for oviduct nuclei in vivo in the preceding paper (Spelsberg, 1976 (Spelsberg et al., 1975) .
Materials and Methods Isolation and analyses of the nuclear materials
Various organs (oviduct, liver, spleen, lung, heart) of adult laying hens were obtained from a local product company (Jones Produce, Rochester, MN, U.S.A.). Within minutes after death, the organs were excised, stripped of fat and connective tissue, sectioned into smaller pieces, and frozen immediately on solid CO2. Mature erythrocytes were isolated as reported previously (Neelin, 1968) . These tissues were then stored at -80°C in a Revco freezer until used. All subsequent steps were performed at 4°C. The isolation and purification of nuclei were performed essentially as described elsewhere (Spelsberg et al., 1971a,b) . The nuclear pellets were resuspended in a 25% (v/v) glycerol solution containing 0.01 M-Tris/HCI (pH 7.5) and 0.001 M-MgCl2 and stored at -20'C until needed.
Steroids
[1 ,2-3H]Progesterone (47.8 Ci/mmol) was obtained from New England Nuclear Corp. (Boston, MA, U.S.A.). The degree of chemical purity of this material was checked by chromatography on t.l.c. plates with benzene/ethyl acetate (7: 3, v/v) as solvent. The stock steroid solution in benzene was frozen, freeze-dried and redissolved in the original volume with ethanol. As needed, this stock was diluted 1: 5 with water and added directly to the cytosol preparations to obtain the progesterone-receptor complexes as described in the next section.
Preparation ofprogesterone-receptor complex
Immature chicks injected for 20-25 days with stilboesterol were used instead of hens so as to avoid the problem of having endogenous progesterone bound to the partially purified receptor. The oviducts were excised, stripped of fat and immediately homogenized in a Waring blender in 3 vol. (v/w) of cold TESH buffer (0.01 M-Tris/HCl, 0.001 M-EDTA, 0.012M-thioglycerol, pH7.4). Homogenization was carried out for 30s at 2000rev./min. The homogenate was re-homogenized briefly in a glass homogenizer with a Teflon pestle and then passed through two layers of cheesecloth. The solution was centrifuged at 20000g,V. for 20min in a J-21 Beckman centrifuge and the supernatant re-centrifuged at l00000gav. for I h in a Beckman L3-50 ultracentrifuge. The l00000gav. supernatant (cytosol) was then assessed for protein concentration by absorption at 280nm and by the method of Lowry et al. (1951) . The solution was then diluted to 20mg of protein/ml. To every 1 ml of this cytosol was added 5,cl of the progesterone solution [80% water and 20% (v/v) ethanol] described in the preceding section. This gives a concentration ofabout 20.9nM-progesterone with juCi of radioactivity/ml. This crude cytosol receptor was then subjected to the (NH4)2SO4-purification procedure described by . The pellets from the (NH4)2SO4 precipitation were frozen and stored at -80°C. When needed, the receptor pellets were resuspended in TESH buffer at half the volume of the original cytosol solution, dialysed in washed dialysis tubing against 20vol. of TESH buffer at 4°C for 2h, and then recentrifuged at lOOOOgav. for 5min to sediment any insoluble material. This hormonereceptor preparation was used directly in the nuclear binding assays. The protein concentration (pg/ml) and radioactivity (d.p.m./ml) were monitored and found to be constant from assay to assay. The integrity of the hormone-receptor complex was monitored as a routine by sucrose-gradient centrifugation and by the charcoal/dextran methods as described previously (Toft & O'Malley, 1972) . Before and after incubation, more than 90% of the radioactivity was bound to a protein sedimenting at 4S under the high-salt conditions as determined by the above techniques.
Preparation ofcytosolfrom non-target tissue
The preparation of spleen cytosol was carried out in the same way as that of the oviduct. After the (NH4)2SO4 pellets were resuspended in TESH buffer, dialysed and centrifuged, 100#1 portions were counted for radioactivity. Because the radioactivity was very low, portions of stock [3H]progesterone solution were again added to the solution to bring the radioactivity up to a value approximating that measured in the cytosol preparation from oviduct.
Assays for nuclear binding
The method for binding of the partially purified progesterone-receptor complex to nuclei simply involves the addition of the labelled hormonereceptor complex to the filters were removed, dried thoroughly, and the DNA was hydrolysed by incubating the filters in 0.3M-HCl04 for 30min at 90°C. The cooled extracts were then assayed for DNA by the diphenylamine reaction (Burton, 1956 It is known for several steroid hormone systems that the receptor needs to be 'activated', either by mild heat treatment or by exposure to higher ionic strength for optimal binding to isolated nuclei (Jensen & DeSombre, 1972; Buller et al., 1975a,b) . It has also been reported that (NH4)2SO4 treatment of the [3H]progesterone-receptor complex from the chick oviduct cytosol appears to simulate this activation process (Buller et al., 1975a,b) . As shown in Fig. 2 Buller et al. (1975b) and has been shown experimentally in our laboratory to be caused in part by the opening of new binding sites in the nucleus, probably by proteolysis. Oviduct nuclei incubated at 23°C for 90min with the crude or partially purified cytosol receptor show proteolytic activity with respect to degradation of histone species, with an accompanying decrease in thermal denaturation, as well as de-repression of the chromatin DNA with respect to its capacity to serve as a template for DNA-dependent RNA synthesis in vitro. Proteolytic activity in nuclei and chromatin has been reported previously (Panyim & Chalkley, 1969) .
The use of the partially purified [3H]progesteronereceptor complex rather than the crude cytosol preparation in the binding assays was found to be more satisfactory for several reasons. First, the stability during storage of the hormone-receptor complex is much better in the former than in the latter. Also, the integrity of the nuclear chromatin, as measured by chemical analysis, polyacrylamide-gel electrophoresis of the proteins and template activity, is better preserved after incubation with the partially purified receptor preparation at 4°C and, especially, at 23°C. Lastly, in assays using relatively low-ionicstrength conditions, the amount of non-receptor cytosol protein which complexes to the nuclei is much less with the partially purified receptor preparation than with the crude cytosol preparation. Consequently, all subsequent nuclear binding assays were performed with the partially purified receptor at 4°C.
To precipitation] from oviduct or spleen cytosol. In Expt. C, oviduct nuclei were incubated as described in the Materials and Methods section with partially purified oviduct cytosol receptor either with or without any complexed [3H]progesterone. After incubation, the nuclei were washed twice in TESH buffer by centrifugation. Any bound receptor was then extracted with 0.4M-KCI in TESH buffer for 30min at 0°C. The nuclei were again sedimented by centrifugation, and the supematant was retained. The DNA of the nuclear pellet was determined by the diphenylamine reaction (Burton, 1956 (Spelsberg, 1976) assay experiments was then studied to assess the possible presence of more than one class of nuclear binding sites. As shown in Fig. 4 , these studies indicate the presence of several classes of binding sites with evident differences in bindingaffinities. Evidence of even more classes of sites has been obtained by using even greater amounts of the hormone-receptor complex. The presence of these multiple binding sites may be responsible for the non-saturability of the nuclear binding sites under the low-ionic-strength conditions (Fig. 3) . Since increasing ionic concentrations cause a decrease in total binding of the [3H] progesterone-receptor complex to nuclei, it is possible that different classes of binding sites are involved. Fig. 4 supports this hypothesis in that an increase in the ionic strength from 0.05M-to 0.15M-KCI causes the elimination of the weaker classes of binding sites, leaving only a highest-affinity class. Gradual increase in ionic strength from 0.15M-to 0.25M-KCI caused a decrease in the radioactivity almost to the background value. The TESH buffer in the reaction mixture additionally adds an equivalent of 0.02M-KCI as determined by conductivity. Not all of the [3Hjprogesterone-receptor complex bound in vivo or in vitro to oviduct nuclei can be dissociated with 0.25M-KCI. In any case, these results suggest that there is more than one class of binding sites detectable in vitro, as in vivo (Spelsberg, 1976) . All of these interactions between the [3H]-progesterone-receptor complex and oviduct nuclei are primarily electrostatic in nature, with each selectively dissociated at specific ionic strengths. Under physiological ionic conditions, only the highest-affinity class of binding sites exists. In Fig. 4 , the equilibrium dissociation constants (Kd) for each class of sites are given. These constants were calculated by using Scatchard-plot analysis (Scatchard, 1949) (Fig. 5 ). An equilibrium dis- The number of binding sites (n) was calculated by assuming 2.5pg of DNA per oviduct nucleus (Sober, 1970) . The Kd was calculated by extrapolating the amount of bound receptor to a 1 litre reaction volume, thus making theKd expressed in mol/ litre per 25mg of DNA. The average of three replicates of analysis was used in these plots of the results in Fig. 4 .
first (highest-affinity) class of binding sites (see Fig. 5a ). The second (next-highest-affinity) class of binding sites has a tenfold less affinity with an equilibrium dissociation constant, Kd = 1.3 x 10-M, representing approx. 20000 sites/cell nucleus (Fig.  Sa) . Scatchard-plot analysis of the third class of binding sites was too variable, so an estimate of the Kd (i 4.0 x 1OM) and the number of sites per cell (approx. 35000) were roughly calculated from a plot of bound versus free receptor, by using estimated half-saturation and saturation values respectively Vol. 156 of the results in Fig. 4 . Fig. $(b) shows a Scatchardplot analysis of the binding to the oviduct nuclei under the higher-ionic-strength condition. The equilibrium dissociation constant, Kd (-:6 x 10-9M), and the number of sites of 10000/cell nucleus are somewhat higher than those observed for the highestaffinity class of binding sites analysed under lowionic-strength conditions. Possibly, the inclusion of a few of the sites of the second-highest-affinity group may still occur under these higher salt conditions.
To confirm that these different classes of binding (Figs. 7a and 7b) . In Fig. 7(a) , the possible presence of a high-affinity class of binding sites is detected in the oviduct (target tissue) nuclei but nQt in the spleen or erythrocyte (non-target tissue) nuclei. Lower-affinity classes of sites are found in the nuclei of non-target as well as target tissues. By applying the high-ionicstrength conditions to analyse binding selectively to the high-affinity class of sites, it was found that the higher-affinity class of sites in whole nuclei was not absolutely tissue-specific (Fig. 7b) . Although spleen and liver nuclei display none of these sites, the presence of a high-affinity class of sites is detected in erythrocyte and lung nuclei, although the extent of binding is lower than that of oviduct nuclei. Under the low-ionic-strength conditions (Fig. 7a) , the maximum extent of hormone binding to nuclei is simnilar for target as well as for non-target tissue, whereas under high-ionic-strength conditions (Fig.  7b) binding. These studies suggest that the cell nuclei of non-target tissue contain either no or a decreased number of high-affinity binding sites compared with cell nuclei from target tissues.
Discussion
The present results clearly show the presence in vitro of different classes of binding sites for the progesterone-receptor complex in hen oviduct nuclei. These sites probably correspond to those described in the preceding paper (Spelsberg, 1976) for the chick oviduct in vivo. The highest-affinity class of binding sites does not appear to be absolutely tissue-specific for whole nuclei, although the extent of binding to these sites is greater for the oviduct (target-cell) nuclei. These results are similar to those reported by Spelsberg et al. (1971b) for progesteronereceptor binding to chick oviduct chromatin. Buller et al. (1975a) also found measurable binding of progesterone receptor to the nuclei of certain non-target tissues.
It is proposed that only the highest-affinity class of binding sites identified in these experiments represents the physiological nuclear binding for progesterone in the hen oviduct nucleus. The reasons for this are threefold. First, it is only logical to assume that the true binding site for steroid-receptor complexes in the nucleus would be one of highest affinity. Secondly, our results show that under the ionic conditions of the cell cytoplasm and the even higher-ionic-strength conditions proposed to exist in the cell nucleus, only the highest-affinity class of binding sites survives. Finally, experiments in which labelled and/or unlabelled progesterone was injected into chicks (Spelsberg, 1976) have shown that the number of molecules of progesterone bound per cell nucleus can be correlated with the endogenous RNA polymerase activities. Not only were multiple binding sites observed under these conditions in vivo, but also, when the number of molecules of progesterone per cell nucleus reached approx. 10000, a maximal alteration in the RNA polymerase activities was observed (Spelsberg, 1976) . Thus the high-affinity sites detected in vitro and representing 6000-10000 progesterone-receptor binding sites per cell nucleus probably represent the biologically active ones.
The lower-affinity classes of binding sites observed in these assays in vitro may or may not have biological significance. Lower-affinity classes of binding sites were observed in vivo in the preceding paper (Spelsberg, 1976) . In any case, these various classes of binding sites in hen oviduct nuclei are readily distinguishable in vitro when the concentration of the hormone-receptor complex is varied. These classes of binding sites display a relatively high affinity (Kd 0 10-8-10-9M) for the [3H]progesteronereceptor complex, which, however, is much lower than that of progesterone for its receptor protein (Kd ;k 10-'O 10-11M).
These studies strongly suggest that binding assays involving steroid hormones and isolated nuclei which differ from each other in ionic concentrations are not measuring the same class of nuclear-binding sites. Studies performed under low-ionic-strength conditions are measuring a non-saturable (adsorptionlike) interaction, whereas those performed under higher-ionic-strength conditions are measuring a high-affinity, saturable-type binding. The tissue specificity of the latter interaction is much more significant than the former interactions.
These conclusions support those made in studies involving immature chicks (Spelsberg et al., 1971b) .
